Owen N. Witte, Director at Allogene Therapeutics, Inc. (ALLO), sold 15,000 shares at $23.24 ($351K) on 2021-08-20, disclosed to the SEC on 2021-08-23.
Open-market sale of $351k ALLO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.24 | 5,000 | $116K | 33.1% |
| 2 | $23.24 | 5,000 | $116K | 33.1% |
| 3 | $23.70 | 5,000 | $119K | 33.8% |
| Total | $23.39 avg | 15,000 | $351K | 100% |
| Filing → |
| ALLO | SELL | 2021-09-09 | $128K | — | Filing → |
| ALLO | SELL | 2021-06-11 | $499K | — | Filing → |
| ALLO | BUY | 2018-10-17 | $270K | — | Filing → |